With the world’s leading technology for screening and mapping of natural immune responses, we test antibodies from single B cells at depths of millions of cells per day. We unlock the power of natural immunity to discover the next generation of antibody therapies.
Diversity, Speed, Throughput, Selectivity
Access to our industry-leading technology and world-class research team is something that our partners clearly value. This includes:
- Faster discovery — Hundreds of high-quality leads, from immunization to purified antibodies in as little as 3 months.
- Deeper screening — More than two orders of magnitude deeper than hybridoma methods to find ultra-rare antibodies with increased diversity.
- Versatile single-cell assays — To select rare antibodies based on cross-reactivity, specificity, competition, affinity, live-cell binding and functional properties.
- Greater diversity — Discoveries made from any tissue and any species, mining untapped antibody sources.
A fully integrated solution for antibody discovery:
Any Target. Any Source.